Abstract
Although rare, extra-pulmonary inflammatory myofibroblastic tumors (IMTs) are becoming increasingly recognized. While surgical resection is currently an effective and accepted treatment for IMTs, the optimal management of unresectable or residual IMTs remains a clinical dilemma. We present the case of an incompletely resected IMT treated successfully with anti-inflammatory therapy alone, and describe the rationale for this approach.
Original language | English (US) |
---|---|
Pages (from-to) | 380-384 |
Number of pages | 5 |
Journal | International Journal of Clinical Oncology |
Volume | 17 |
Issue number | 4 |
DOIs | |
State | Published - Aug 1 2012 |
All Science Journal Classification (ASJC) codes
- Surgery
- Hematology
- Oncology